Jean-Etienne Fabre
Jean-Etienne Fabre
Verified email at
TitleCited byYear
Age-dependent impairment of angiogenesis
A Rivard, JE Fabre, M Silver, D Chen, T Murohara, M Kearney, M Magner, ...
Circulation 99 (1), 111-120, 1999
Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice
JE Fabre, MT Nguyen, A Latour, JA Keifer, LP Audoly, TM Coffman, ...
Nature medicine 5 (10), 1199, 1999
Tissue inhibition of angiotensin-converting enzyme activity stimulates angiogenesis in vivo
JE Fabre, A Rivard, M Magner, M Silver, JM Isner
Circulation 99 (23), 3043-3049, 1999
Cardiovascular Responses to the Isoprostanes iPF-III and iPE2-III Are Mediated via the Thromboxane A2 Receptor In Vivo
LP Audoly, B Rocca, JE Fabre, BH Koller, D Thomas, AL Loeb, ...
Circulation 101 (24), 2833-2840, 2000
Activation of the murine EP3 receptor for PGE2 inhibits cAMP production and promotes platelet aggregation
JE Fabre, MT Nguyen, K Athirakul, K Coggins, JD McNeish, S Austin, ...
The Journal of clinical investigation 107 (5), 603-610, 2001
Vascular wall–produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors
S Gross, P Tilly, D Hentsch, JL Vonesch, JE Fabre
Journal of Experimental Medicine 204 (2), 311-320, 2007
Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo
JE Fabre, JL Goulet, E Riche, MT Nguyen, K Coggins, S Offenbacher, ...
The Journal of clinical investigation 109 (10), 1373-1380, 2002
Identification of P2Y12-dependent and-independent mechanisms of glycoprotein VI–mediated Rap1 activation in platelets
MK Larson, H Chen, ML Kahn, AM Taylor, JE Fabre, RM Mortensen, ...
Blood 101 (4), 1409-1415, 2003
Antagonists of the EP3 Receptor for Prostaglandin E2 Are Novel Antiplatelet Agents That Do Not Prolong Bleeding
J Singh, W Zeller, N Zhou, G Hategen, R Mishra, A Polozov, P Yu, E Onua, ...
ACS chemical biology 4 (2), 115-126, 2009
Lack of oxygen supply dependency in patients with severe sepsis: A study of oxygen delivery increased by military antishock trouser and dobutamine
JP Mira, JE Fabre, F Baigorri, J Coste, G Annat, A Artigas, G Nitenberg, ...
Chest 106 (5), 1524-1531, 1994
Magnetic resonance molecular imaging of thrombosis in an arachidonic acid mouse model using an activated platelet targeted probe
A Klink, E Lancelot, S Ballet, E Vucic, JE Fabre, W Gonzalez, C Medina, ...
Arteriosclerosis, thrombosis, and vascular biology 30 (3), 403-410, 2010
Limitations of current therapies to prevent thrombosis: a need for novel strategies
JE Fabre, ME Gurney
Molecular BioSystems 6 (2), 305-315, 2010
Periodontal and systemic responses in various mice models of experimental periodontitis: respective roles of inflammation duration and Porphyromonas gingivalis infection
K Saadi‐Thiers, O Huck, P Simonis, P Tilly, JE Fabre, H Tenenbaum, ...
Journal of periodontology 84 (3), 396-406, 2013
Blocking the EP3 receptor for PGE2 with DG-041 decreases thrombosis without impairing haemostatic competence
P Tilly, AL Charles, S Ludwig, F Slimani, S Gross, O Meilhac, B Geny, ...
Cardiovascular research 101 (3), 482-491, 2013
Early cell loss after angioplasty results in a disproportionate decrease in percutaneous gene transfer to the vessel wall
A Rivard, Z Luo, H Perlman, JE Fabre, T Nguyen, L Maillard, K Walsh
Human gene therapy 10 (5), 711-721, 1999
Effects of poloxamer 407 on transfection time and percutaneous adenovirus-mediated gene transfer in native and stented vessels
E van Belle, L Maillard, A Rivard, JE Fabre, T Couffinhal, M Kearney, ...
Human gene therapy 9 (7), 1013-1024, 1998
Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa
C Geary, H Akinbi, T Korfhagen, JE Fabre, R Boucher, W Rice
American Journal of Physiology-Lung Cellular and Molecular Physiology 289 (5 …, 2005
In vivo detection of activated platelets allows characterizing rupture of atherosclerotic plaques with molecular magnetic resonance imaging in mice
D von Elverfeldt, C von Zur Muhlen, K Wiens, I Neudorfer, A Zirlik, ...
PLoS One 7 (9), e45008, 2012
Extracellular Ca2+ modulates ADP‐evoked aggregation through altered agonist degradation: implications for conditions used to study P2Y receptor activation
S Jones, RJ Evans, MP Mahaut‐Smith
British journal of haematology 153 (1), 83-91, 2011
The receptor EP3 to PGE2: a rational target to prevent atherothrombosis without inducing bleeding
MA Mawhin, P Tilly, JE Fabre
Prostaglandins & other lipid mediators 121, 4-16, 2015
The system can't perform the operation now. Try again later.
Articles 1–20